Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-52 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-803 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-02 |
filingDate |
2000-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2003-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98869184d225640cf7b42622ade28eb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba61905bb8196829f1dc5947e358a658 |
publicationDate |
2003-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6548523-B2 |
titleOfInvention |
Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties |
abstract |
The present invention is a process for the preparation of a compound of Formula (IA) or a pharmaceutically acceptable salt thereof: n that includes preparing a diamide of Formula (II) or a pharmaceutically acceptable salt thereof: |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004189487-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10350182-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7868144-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10751311-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10844004-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10065922-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9394239-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10221126-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9907767-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010286275-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11691944-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8778998-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9526711-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005019827-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10668034-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9956194-B2 |
priorityDate |
1999-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |